2nd Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts. Rare diseases need innovative therapies
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F25%3A00143465" target="_blank" >RIV/00216224:14110/25:00143465 - isvavai.cz</a>
Výsledek na webu
<a href="https://creatic.muni.cz/creatic/conferences/creatic-conference-2025" target="_blank" >https://creatic.muni.cz/creatic/conferences/creatic-conference-2025</a>
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
2nd Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts. Rare diseases need innovative therapies
Popis výsledku v původním jazyce
The CREATIC conference brings together leading experts from academia, clinical settings and research institutions from across the European region to jointly address challenges in the field of advanced therapies and rare diseases. The importance of advanced therapy medicinal products (ATMPs) and their remarkable outcomes for patients is increasingly recognized within the European Union. The two-day CREATIC conference is divided into five thematic sections, focusing on supporting innovation in ATMPs through networking, navigating ATMP regulation and reimbursement, innovation in cellular and gene ATMP research and development, personalized medicine in rare diseases – from precision genomics to GMP manufacturing – and the translation of ATMPs from the laboratory to patients.
Název v anglickém jazyce
2nd Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts. Rare diseases need innovative therapies
Popis výsledku anglicky
The CREATIC conference brings together leading experts from academia, clinical settings and research institutions from across the European region to jointly address challenges in the field of advanced therapies and rare diseases. The importance of advanced therapy medicinal products (ATMPs) and their remarkable outcomes for patients is increasingly recognized within the European Union. The two-day CREATIC conference is divided into five thematic sections, focusing on supporting innovation in ATMPs through networking, navigating ATMP regulation and reimbursement, innovation in cellular and gene ATMP research and development, personalized medicine in rare diseases – from precision genomics to GMP manufacturing – and the translation of ATMPs from the laboratory to patients.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
30230 - Other clinical medicine subjects
Návaznosti výsledku
Projekt
<a href="/cs/project/LM2023049" target="_blank" >LM2023049: Český národní uzel Evropské sítě infrastruktur klinického výzkumu</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů